07/08/2018 |
AMIGOS-2 study |
CIGB |
Registered outdated |
07/08/2018 |
CERVICONC-II-300 study |
CIGB |
Registered outdated |
28/12/2018 |
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
CIM |
Registered outdated |
28/09/2018 |
Topic Oleozon in patients with epidermophytosis |
CPN |
Registered outdated |
15/04/2019 |
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT |
BIOCEN |
Registered outdated |
28/11/2018 |
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
ABOCA |
Registered outdated |
14/03/2019 |
COURAGE-2 Study |
CIGB |
Registered outdated |
14/01/2019 |
Melagenina Plus - Vitiligo – phase IV |
CHP |
Registered outdated |
28/05/2020 |
ATENEA-Co-300 study |
CIGB |
Registered outdated |
01/03/2021 |
AVATAR-2020 |
CIGB |
Registered outdated |
22/10/2020 |
CIMAvax-EGF in patients at high risk of lung cancer |
CIM |
Registered outdated |
11/08/2020 |
DALIA Study |
CIGB |
Registered outdated |
14/05/2020 |
CIGB-258 at COVID-19 |
CIGB |
Registered outdated |
29/05/2020 |
Heberon Alfa R in COVID-19 |
MINSAP_AM |
Registered outdated |
03/07/2020 |
Stem cells in patients with lung lesions (COVID-19) |
IHI |
Registered outdated |
03/07/2020 |
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
IHI |
Registered outdated |
22/06/2020 |
VIDA study |
CIGB |
Registered outdated |
14/07/2020 |
Safety and immunogenicity of the CIGB 2020. |
CIGB |
Registered outdated |
11/08/2020 |
CIMAvax-EGF in Bladder cancer |
CIM |
Registered outdated |
13/08/2020 |
SOBERANA 01 |
FINLAY |
Registered outdated |